
-
Ampio Pharmaceuticals Inc OTC Markets OTCPK:AMPE Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Location: 9800 Mount Pyramid Court, Englewood, CO, 80112, United States | Website: https://ampiopharma.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-3.669M
Cash
4.123M
Avg Qtr Burn
-2.141M
Short % of Float
2.94%
Insider Ownership
1.53%
Institutional Own.
0.04%
Qtr Updated
12/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ampion (Osteoarthritis) Details Osteoarthritis pain, Joint disease, Arthritis | Failed Discontinued | |
Ampion Details COVID-19 | Failed Discontinued |